期刊文献+

胱抑素C与随机尿微量清蛋白/尿肌酐比值对原发性高血压病早期肾损害的诊断价值 被引量:11

下载PDF
导出
摘要 目的探讨血清胱抑素C(CysC)与尿微量清蛋白/尿肌酐(UmAlb/UCr)比值对诊断原发性高血压(EH)早期肾损害的临床价值。方法以83例EH患者为EH组、38例体检健康者对照组,同时测定血清CysC、UmAlb、UCr含量,计算UmAlb/UCr比值。结果 EH患者血清CysC含量、UmAlb/UCr比值高于对照组(P<0.05),EH患者各亚组间的比较差异也有统计学意义(P<0.05);血清CysC、UmAlb/UCr联合检测诊断EH患者肾损害的灵敏度为91.43%、特异度为97.67%、阳性预测值为94.12%、阴性预测值为96.55%。结论血清CysC及UmAlb/UCr联合检测可提高对EH患者早期肾损害的诊断灵敏度,具有临床实用价值。
出处 《国际检验医学杂志》 CAS 2011年第13期1515-1517,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献10

  • 1Stam F,Guldener C,Schalkwijk CG,et al.Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity[J].Nephrol Dial Transplant,2003,18(5):892-898.
  • 2Dieterle F,Sistare FD.Biomarkers of acute kidney injury[M]Hoboken,USA:John Wiley & Sons,2010.
  • 3Anderson RJ,Barry DW.Clinical and laboratory diagnosis of acute renal failure[J].Best Pract Res Clin Anaesthesiol,2004,18(1):1-20.
  • 4Ritz E,Adamczak M,Zeier M.Kidney and hypertension-causes.Update 2003[J].Herz,2003,28(8):663-667.
  • 5Hall JE.The kidney,hypertension,and obesity[J].Hypertension,2003,41(3 Pt 2):625-633.
  • 6陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 7蔡钢强,垢敬,焦连亭.胱抑素C的生物学特性及临床应用评价[J].国际检验医学杂志,2006,27(5):457-460. 被引量:57
  • 8Segura J,Ruilope LM,Rodicio JL.Microalbuminuria[J].Clin Exp Hypertens,2004,26(7-8):701-707.
  • 9蒋新颖,孔宝坤.尿微量白蛋白/肌酐比值对高血压及糖尿病早期肾损害的诊断价值[J].中国血液流变学杂志,2006,16(4):665-665. 被引量:8
  • 10贺丹,柴华旗,黎曼.晨尿尿蛋白/尿肌酐比和24h尿蛋白定量的临床评价[J].苏州大学学报(医学版),2004,24(6):861-863. 被引量:16

二级参考文献27

  • 1魏有仁,侯林浦,王玫,湛玉良,朱立华.尿中微量白蛋白的测定及应用[J].生物化学与生物物理进展,1995,22(2):169-173. 被引量:84
  • 2孙培荣,石永兵.尿白蛋白/肌酐比值对诊断早期糖尿病肾病的价值[J].国际泌尿系统杂志,2006,26(4):573-575. 被引量:39
  • 3Strevens H. Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomcrular endotheliosis in normal, hypertensive and preeclamptic pregnancies. BJOG, 2003, 110(9): 825-830.
  • 4Herget-Rosenthal S, Trabold S, Huesing J, et al. Cystatin C-an accurate marker of glomerular filtration rate after renal transplantat on? Transpl Int, 2000, 13(4): 285-289.
  • 5Janowski R, Kozak M, Jankowska E, et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol, 2001, 8(4): 316-320.
  • 6Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superiot to serum creatinine as a marker of Kidney function., a meta-analysis. Am J Kidney Dis, 2002, 40(2): 221-226.
  • 7Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem, 2001, 47(11): 2055-2059.
  • 8Bokenkamp A, van-Wijk JA, Lentze MJ, et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem, 2002, 48(7):1123-1126.
  • 9Schmitt R, Bachmann S. Impact of thyroid dysfunction on serum cystatin C. Kidney Int, 2003, 64(3): 1139-1140.
  • 10Wiesli P, Schwegler B, Spinas GA, et al. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta, 2003,338(1-2): 87-90.

共引文献1765

同被引文献115

引证文献11

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部